Reuters logo
BRIEF-Argenx presents update on phase I data from ARGX-110 expansion study
2017年6月14日 / 早上6点07分 / 4 个月前

BRIEF-Argenx presents update on phase I data from ARGX-110 expansion study

June 14 (Reuters) - ARGENX NV

* REG-ARGENX PRESENTS UPDATE ON PHASE I DATA FROM ARGX-110 EXPANSION STUDY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS AT THE INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA (ICML) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below